Disease | retinopathy, diabetic |
Comorbidity | |diabetes |
Sentences | 91 |
PubMedID- 26311693 | Conclusion: there was no significant association between enos gene vntr 4a/b polymorphism and diabetic retinopathy (dr) in patients with type 2 diabetes mellitus. |
PubMedID- 21629574 | The exclusion criteria were 1) previous ocular surgery, 2) diabetes mellitus with diabetic retinopathy, 3) previous macular laser photocoagulation, 4) previous intravitreal injection of triamcinolone acetonide or anti-vegf agents, 5) a history of ocular inflammation, 6) marked retinal hemorrhage (including macular bleeding involving the intrafoveal or subfoveal spaces), and 7) serous retinal detachment. |
PubMedID- 24093530 | In populations like this who are regularly screened for diabetes, the prevalence of diabetic retinopathy is low 4. in those who present symptomatically with diabetes, the onset of diabetes is estimated 5,6 to be 4–7 years before diagnosis and the prevalence of retinopathy is reported to be higher 2.is this attributable to the screening programme not being informed in a timely fashion of the diagnosis? |
PubMedID- 25172198 | The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the action to control cardiovascular risk in diabetes (accord) eye study. |
PubMedID- 20871662 | To identify genetic loci for severe diabetic retinopathy, 286 mexican-americans with type 2 diabetes from starr county, texas, completed physical examinations including fundus photography for diabetic retinopathy grading. |
PubMedID- 22709833 | Conclusions: there are now robust and consistent clinical data to recommend fenofibrate as an adjunctive treatment for early diabetic retinopathy in patients with type 2 diabetes mellitus, taking into account the risks vs benefits of therapy. |
PubMedID- 22412857 | In type 2 diabetes, the overall prevalence of diabetic retinopathy was 39.5%, of clinically significant macular oedema was 4.7% and sight threatening diabetic retinopathy was 8.3% in keeping with estimates generated by other contemporary studies in the us and uk [4]–[5]; [13]–[14]. |
PubMedID- 20444917 | Design, setting, and subjects: in this study we compared vegf gene variants in a sample of korean type 2 diabetes patients with and without diabetic retinopathy (dr) and in healthy controls. |
PubMedID- 24279470 | There were positive correlations between vegf and glucose levels and between vegf and ferritin in diabetes groups, especially in patients with diabetic retinopathy. |
PubMedID- 24119962 | Objective: to investigate the association of diabetic self-management with the risk of diabetic retinopathy (dr) in patients with type 2 diabetes mellitus. |
PubMedID- 22262266 | Objective: to estimate the prevalence of diabetic retinopathy (dr) in patients with type 2 diabetes and to determine any association with clinical factors. |
PubMedID- 24339677 | The prevalence of diabetic retinopathy increases with duration of diabetes and nearly all patients with type 1 and more than 60% with type 2 diabetes develop some signs of retinopathy after 20 years duration. |
PubMedID- 24819633 | Genediab included 444 patients with type 1 diabetes and diagnosis of severe diabetic retinopathy [4]. |
PubMedID- 21775765 | Prevalence of and risk factors for diabetic retinopathy in koreans with type ii diabetes: baseline characteristics of seoul metropolitan city-diabetes prevention program (smc-dpp) participants. |
PubMedID- 22696851 | Objective: to evaluate the prevalence and associated factors of diabetic retinopathy (dr) in patients with type 2 diabetes in the diabetes clinic at chandrubeksa hospital. |
PubMedID- 25986974 | Conclusions: pro-- inflammatory serum cytokine levels were higher in the diabetes mellitus with diabetic retinopathy group. |
PubMedID- 25880194 | In this study our primary objective is to explore the role of slmap gene polymorphisms in the susceptibility of type 2 diabetes (t2dm) with or without diabetic retinopathy (dr) in the qatari population. |
PubMedID- 20532019 | Although the good correlation of diabetes duration with diabetic retinopathy (r = 0.516, p < 0.01) may lessen this concern, another prospective study for individuals with newly detected type 2 diabetes is needed to confirm the results of our study. |
PubMedID- 24614131 | Kim [31] reported that sch was independently associated with severe diabetic retinopathy in patients with type 2 diabetes and the prevalence of severe diabetic retinopathy was significantly higher in the subclinical hypothyroidism group than the euthyroid group (32.8% vs. 19.6%, p = 0.036). |
PubMedID- 23923399 | Gliclazide is an oral hypoglycemic agent, indicated in non insulin dependent diabetes mellitus and in patients with diabetic retinopathy. |
PubMedID- 22279252 | Role of early screening for diabetic retinopathy in patients with diabetes mellitus: an overview. |
PubMedID- 24684063 | Objective: to investigate dynamic changes of pathogenically significant factors of tear fluid in type 2 diabetes patients with hemorrhagic proliferative diabetic retinopathy. |
PubMedID- 20809910 | Conclusion: the prevalence of diabetic retinopathy in persons with diabetes in this study was low. |
PubMedID- 24772145 | Objective: to determine the frequency, severity and risk indicators of diabetic retinopathy (dr) in patients with diabetes attending a primary care diabetes centre. |
PubMedID- 23658123 | The severity of diabetic retinopathy was positively associated with diabetes duration, blood glucose indexes and vibration perception threshold (all p < 0.01). |
PubMedID- 25822410 | High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with proliferative diabetic retinopathy. |
PubMedID- 22139892 | Results: the prevalence of diabetic retinopathy in patients with diabetes and impaired glucose regulation subjects was 9.4% and 2.5%, respectively. |
PubMedID- 23366177 | All people with diabetes have the risk of developing diabetic retinopathy (dr), a vision-threatening complication. |
PubMedID- 25866794 | One study found that latanoprost (a pgf2α agonist) used topically significantly reduced dilation of retinal arterioles in type i diabetes patients with diabetic retinopathy, whereas topical diclofenac had no significant effect [77]. |
PubMedID- 26124993 | Elevated serum ceruloplasmin levels have been observed in both type 1 and type 2 diabetes [67] and in patients with diabetic retinopathy [8]. |
PubMedID- 25983216 | Participants: three hundred ninety-six patients aged >/=18 years, with type 1 or 2 diabetes mellitus, bcva of 78-39 early treatment diabetic retinopathy study (etdrs) letters, and visual impairment resulting from dme. |
PubMedID- 25534877 | In general, the short-term glycemic fluctuation, either expressed as standard deviation of fasting glucose or mean glucose levels, may contribute to the development or progression of diabetic retinopathy in patients with type 2 diabetes, whereas long-term glycemic fluctuation, reflected by variation of levels of hba1c, appeared to show a stronger association with diabetes retinopathy both in patients with type 1 and type 2 diabetes. |
PubMedID- 26019380 | Objective: to evaluate the impact of a strategy for early detection of diabetic retinopathy in patients with type 2 diabetes mellitus (dmt2) in quintana roo, mexico. |
PubMedID- 21273947 | Purpose: to establish the correlation between ischemia-modified albumin (ima) and malondialdehyde (mda) and the development of diabetic retinopathy (drp) in patients with diabetes mellitus. |
PubMedID- 22747972 | Background: previous studies have reported that microalbuminuria is an independent risk factor for the prevalence of diabetic retinopathy (dr) in patients with type 2 diabetes mellitus (dm). |
PubMedID- 21528431 | The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus. |
PubMedID- 22471351 | Also, older patients with diabetes are at risk of developing diabetic retinopathy [15]. |
PubMedID- 24876413 | In the united states, more than 25 million adults have diabetes, 40% of diabetics have diabetic retinopathy, and diabetes is the leading cause of blindness in people 20 to 74 years of age. |
PubMedID- 21745362 | The r217x mutation has been linked to the development of type 2 diabetes mellitus complicated by diabetic retinopathy in a patient with laron-type dwarfism who had never been treated with rigf-1 [14]. |
PubMedID- 21819502 | The prevalence of diabetic retinopathy in people with diabetes is similar to that of non-indigenous australians. |
PubMedID- 25447109 | Purpose: to assess the accuracy and reliability of smartphone ophthalmoscopy, we compared the ability of a smartphone ophthalmoscope with that of a slit-lamp biomicroscope to grade diabetic retinopathy (dr) in patients with diabetes mellitus (dm). |
Page: 1 2